Internal Medicine
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
22 May, 2020 | 04:59h | UTCCommentary: Lungs of deceased COVID-19 patients show distinctive features – Brigham and Women’s Hospital
Related: Postmortem Examination of Patients With COVID-19 – JAMA AND Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine AND Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis
How Coronavirus Lockdowns Stopped Flu in its Tracks
22 May, 2020 | 04:53h | UTCHow coronavirus lockdowns stopped flu in its tracks – Nature
“Reported rates of influenza and other infections have fallen sharply, but some communicable diseases may see a rise.”
15 Drugs Being Tested to Treat COVID-19 and How They Would Work
22 May, 2020 | 04:52h | UTC15 drugs being tested to treat COVID-19 and how they would work – Nature
[Preprint] IL6 Inhibition in Critically Ill COVID-19 Patients is Associated with Increased Secondary Infections
22 May, 2020 | 04:44h | UTC
Opinion: Revisiting the No Visitors Policy
22 May, 2020 | 04:43h | UTCRevisiting the No Visitors Policy – CMAJ Blogs
“I follow the policy, as I must, but neither my heart nor my mind believe that the harm we aim to prevent with current no visitors edicts outweighs the harm we are causing.”
Wide Complex Tachycardia Differentiation: A Reappraisal of the State‐of‐the‐Art
22 May, 2020 | 04:38h | UTC
Observational Study Suggests Possible Benefit from Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
21 May, 2020 | 09:23h | UTCRelated: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
Olfactory Dysfunction in COVID-19: Diagnosis and Management
21 May, 2020 | 09:24h | UTCOlfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA
Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford
Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease
21 May, 2020 | 09:18h | UTCCommentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology
Cardiovascular Considerations in Treating Patients with COVID-19
21 May, 2020 | 09:16h | UTCRelated: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD
See also: COVID-19: Updates for Cardiologists
Rate of Diagnostic Errors and Related Harms for Major Vascular Events, Infections, and Cancers
21 May, 2020 | 09:14h | UTCCommentary: Misdiagnoses Common, With Permanent Disability, Death for Many – Medscape (free registration required)
Neurologic Complications of COVID-19
21 May, 2020 | 09:15h | UTCNeurologic complications of COVID-19 – American Journal of Emergency Medicine
Related: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries) AND Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology
[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious
20 May, 2020 | 10:00h | UTCCovid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg
Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs
20 May, 2020 | 09:58h | UTCOriginal Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics
Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19
20 May, 2020 | 10:01h | UTCLack of efficacy of hydroxychloroquine in covid-19 – The BMJ
Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ
Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv
Reducing the Risk of Diagnostic Error in the COVID-19 Era
20 May, 2020 | 09:57h | UTCReducing the Risk of Diagnostic Error in the COVID-19 Era – Journal of Hospital Medicine
Video: Personal Protective Equipment and Covid-19
20 May, 2020 | 09:55h | UTCPersonal Protective Equipment and Covid-19 – New England Journal of Medicine
Cohort Study: Outcomes of Critically Ill Adults with COVID-19 in New York City
20 May, 2020 | 09:56h | UTCCommentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI
Study Shows Lower Incidence of Hospitalization for Acute Myocardial Infarction After the Covid-19 Pandemic
20 May, 2020 | 09:54h | UTCRelated Study: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine
Serology for SARS-CoV-2: Apprehensions, Opportunities, and the Path Forward
20 May, 2020 | 09:53h | UTCSerology for SARS-CoV-2: Apprehensions, opportunities, and the path forward – Science Immunology
Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19
20 May, 2020 | 09:50h | UTCRelated Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv
Meta-Analysis: Accuracy of Chest CT for detecting COVID-19
20 May, 2020 | 09:49h | UTC
Meta-Analysis: Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment
20 May, 2020 | 09:45h | UTCAssociation of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis – JAMA (free for a limited period)
Commentary: Controlling blood pressure may reduce dementia risk by 7% – UPI
Meta-analysis: Utility of Broad-spectrum Antibiotics for Diagnosing Pulmonary Tuberculosis in Adults
20 May, 2020 | 09:44h | UTCCommentary: The uncertainty of tuberculosis diagnosis – The Lancet Infectious Diseases
Should Azithromycin be Used to Treat COVID-19?
20 May, 2020 | 09:47h | UTCShould azithromycin be used to treat COVID-19? A rapid review – BJGP Open